<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 126 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page125.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=126">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 126 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 126</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=126"><img src="../thumb/126.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Cardio-Vascular Agents - 7.3 / 7.3.1 / 7.3.2 / 7.3.3                            2020-04 / 95
                                     CARDURA XL, Pfizer [P/S] &   Adults: 1 tab.dly.
       7.3    Anti-hypertensives     Doxazosin.                   Contraindications: Orthostat.hypotens., other concom. alpha 1-
                                                                  adrenocept.block., hepat.insuffic., sev. ren.insuffic., childr., safety &
                                     Indications: Mild to mod.hypertens., reduc.urin. flow & sympts.
              (Single agents and     assoc.with BPH.              effic.in pregn.& lactat. not est.
                                     (S3) TABS, 32/7.1/0556, 0557
                                                                  Side effects: Postur.hypotens., faintn., vertigo., dizzin., headache,
              combinations including   869856-006: 4 mg, 30, R333,99  drowsin., syncope, tachycard., palpitat., oed., flushes, chest pain.,
                                     869864-009: 8 mg, 30, R461,88
                                                                  GI disturbs., dry mouth, rash, prurit., asthen., malaise.
              diuretic combinations)  Dosage: For pts est.on convent.tabs.of 1-4 mg dly.maybe control.  Special precautions: Cont.coron.artery dis. treatm., discont.if ang.
                                     on XL 4 mg & those est.on convent.8 mg may be control.on XL 8
                                                                  pect.reappears/worsens, not indicat.in elderly./treat.hypertens.pts.
                                     mg. Swallow whole.           as 5 mg dos. form not avail.
       7.3.1   Central acting        Hypertens: 4 mg once dly.,incr.if necess.to 8 mg once dly.accord.to   Drug interactions: Poss postur.hypotens.with antihypertens.
                                     respon. Use in combinat.with a thiazide diuret./ß-block.if neccess.
                                                                  meds.& alpha 1-adrenocept.block., decr.BP.with gen.anaesth.
              sympathetic nervous    BPH: 4 mg once dly. Depend.on urodynam.& BPH symptomatology   SILODYX, Litha Pharma (Pty) Ltd
                                     dos may be.incr.at interv.of 1-2 wks. to 8 mg dly.
                                                                  See Section 16.5
                                     Contraindications: Quinazoline hypersens., hist. of GI/oesophag.
              system inhibitors      obstruct., decr.in GIT lumen diam., safety in pregn./lactat./childr.  TAMSUL, Aspen Pharmacare (Pty) Ltd
                                     not est.
              (See also 16.1)        Side effects: Dizzin., palpit., tachycard., vertigo, GI disturbs., dry   See Section 16.5
                                     mouth, asthen., chest pain, periph. oed., RT & UT infects., back pain,   URODOXA, Aurobindo [P/S]
       HY-PO-TONE, (Aspen Pharmacare: Pharma) Pharmacare [P/S]  myalg., headache, somnol., cystit., urin.incontin./disords., cough.,   Doxazosin.
       Methyldopa.                   dyspn., rhinit., prurit., hypotens., postur. hypotens., leucopaen., throm-  Indications: Mild to mod.hypertens., urin.outflow obstruct.&
       Indications: Essen.hypertens.  bocytopaen., ang. pect., MI, card. dysrythm., tinnit., blurr.vis., intra-  sympts.assoc.with BPH.
       (S3) TABS. K/7.1.3/90, 209.   operat.floppy iris syndr., fatig., malaise, cholestas., hepatit., jaund., al-  (S3) TABS, 45/7.1/0152
       732052-009: 250 mg, 100, R103,20  lerg.reacts., abnorm. LFT, weight incr., arthralg., musc.cramps/weakn.,   3000184-001: 4 mg, 30, R64.52
       732052-017: 250 mg, 500, R516,02  CVA, anx., depress., insomn., agitat., nervousn., impot., gynaecomast.,   Dosage: Hypertens: Init: 1 mg once dly. Depend. on respons.incr.aft.
       732079-004: 500 mg, 100, R382,06  priap., retrogr.ejaculat., epistax., skin rash, alopec., purpura, urticar.,   1-2 wks to 2 mg and then at similar interv.to 4 mg, 8 mg and 16 mg
       Dosage: Init.250 mg 2-3xdly for 1st 48 hrs, thereaft. adjust in   hot flushes, plasma conc of triglycerides./tot.& LDL cholest. reduc. &   to achieve desir.respons. If adeq.control.not achiev.with sngl. agent
       48 hr.interv.till adeq.respon. usual. 0,5-2 g dly. Childr: 10 mg/kg   HDL cholester.incr., bradycard., influ.-like sympts., pain, anorex., par-  may be combin.with thiazide diuret./ß-block.
       bm dly.in div.dos.            aesthes., hypoaesthes., trem., syncop., bronchosp.aggrav.  BPH: Init: 1 mg once dly. Depend.on urodynam.& BPH symptoma-
       Contraindications: Imp.liv./kidn.funct., liv.dis. hist., ac.hepat.dis.,   Warnings and special precautions: Caut.pt.of poss. postur.hypo-  tology dos may be.incr.at interv.of 1-2 wks to 2 mg and then to 4 mg,
       depress., phaeochromocytoma, porphyr., MAOI’s, safety in pregn.&   tens., concom.PDE-5 inhibit.as symptomat. hypotens.poss., imp.liv.  with max.of 8 mg. Usual recomm.dos is 2-4 mg dly.
       lactat.not est.               funct., intraoperat. floppy iris syndr.dur.cataract surg.  Contraindications: Other quinazoline hypersens., hist. of orthos-
       Side effects: Bld.disords., drug fev., jaund., psych. disords., CNS   See also MDR page 595.  tat. hypotens., BPH pts.with concom. congest. of upper UT/chron.
       eff., headache, invol.chorioathetot. movem., Bell’s palsy, parkinson.,   CARZIN XL, Pharma Dynamics [P/S]  UTI/bladd.stones., monother. in pts.with either overfl.bladd./anuria/
       oed., bradycard., postur. hypotens.with weakn./dizzin./ lighthead-  Doxazosin  without progress.ren.insuffic., safety & effic.not est.in childr., safety
       edn., myocardit., ang.pect. aggravat., GI disords., pancreatit., saliv.  Indications: Mild to mod.hypertens., urin.outflow obstruct., sympts   in pregn.& lactat.not est., lact.intol.
       gland inflamm., black/ sore tong., fatal hepat.necros., skin reacts.,   assoc.with BPH.  Side effects: Freq: Dizzin., vertigo, headache, asthen. Less freq:
       arthralg., myalg., uraem., SLE-like condit., imp.sex. funct., incr.ser.  (S3) TABS, 41/7.1/0557  Nervousn., somnol., cardiac dysrhythm., palpitat, tachycard., hypo-
       prolact.lev.with breast enlargem./ lactat., nas.stuffin., darken.urine.  714292-001: 4 mg, 30, R148,75  tens., dyspn., rhinit., nausea, abdom.pain., priapism. Unknown freq:
       Special precautions: Cross.placenta, pass.into breast milk,   Dosage: Hypertens: Usual dos: 4 mg once dly. If necess.may be   Thrombocytopen., leukopen., allerg.reacts., depress., insomn., agitat.,
       anaesth., Li toxic., concom.other potent.hepatox.agents esp.halo-  incr.to 8 mg once dly. If adeq. control. not achiev.with sngl.agent may   tremor, paraesthes., postur. dizzin., blurr./abnorm.vis., MI, ang.pect.,
       thane not advis., liv. damage aft.longt.admin., LFT at interv.dur.1   st  be combin. with thiazide diuret./ß-block.  cerebrovasc. accid., epistax., diarrh., dry mouth, vomit., jaund., hep-
       6-12 treatm.wks./if unexpl.fev.devel.  BPH: Usual dos: 4 mg once dly. Depend.on indiv. urodynam.& BPH   atit., cholestas., skin rash., prurit., purpura, haematur., urin.incont.,
       Drug interactions: Reduc.eff.with phenothiazin./ sympathom-  symptomatology dos may be incr. to 8 mg once dly. Recomm.titrat.  sex. dysfunct., impot., fatigue, malaise, chest pain, oed., abnorm. LFTs.
       imets./imipramine/other TCA’s/ MAOI’s.  interv.1-2 wks.    Warnings and special precautions: Not recommend. for treatm.
                                     Contraindications: Other quinazoline hypersens., GI/oesophag.  of HF caus.by mechanic. obstruct. incl. aortic stenos./mitral valve
                                     obstruct.hist.or any degr.of decr.GIT lumen diamet., safety & ef-  stenos./ pulm. embol./restrict.pericard.dis., discont.if sympt. of ang.
       7.3.2   Alpha-receptor blockers  fic.not est.in childr., not recomm.in sev.hepat.impairm., safety in   pect.develop./worsen, poss.syncope aft. init.dos./incr.dos.in sympto-
                                     pregn.& lactat.not est.
                                                                  mat.hypotens., mild to mod. imp.hepat./ren.funct., elderly, intraoperat.
       CARDURA XL (MDR Listing)      Side effects: Leucopen., thrombocytopen., depress., CNS effs.,   floppy iris syndr.risk.dur.cataract surg., excl. prostate Ca bef.init.ther.,
                                     anx., insomn., agitat., nervousn., hallucinat., confus., paranoia,   init.concom.PDE-5 inhibits. at low.dos., eval.BP routinely in BPH pts.
       ALFUWIN XL, Zentiva [P/S]     vertigo, headache, hypoesthes., paraesthes., blurr.vis., arrhythm.,   Interactions: Hypotens.eff.potent.by diuret. /other antihypertens./
       Alfuzosin                     palpit., tachycard., bradycard., MI, chest pain, ang.pect., hypotens.,   PDE-5 inhibits/alcoh.or other meds. caus. hypotens., sympathom-
       Indications: Funct.sympts.of benign prostat. hyperplas., adjunct.  orthostat.hypotens., periph. oed., CVA, syncope, vertigo, hot flush.,   imet.& NSAID’s reduc. hypotens.eff.
       with urethral catheterisat.for ac.urin.retent.relat.to benign pros-  dyspn., RTI, rhinit., aggrav.bronchosp., weight incr., GI disturbs.,
       tat. hyperplas.,              anorex., diaphores., dry mouth, naus., hepatit., jaund., abnorm.LFT,   XATRAL, Sanofi-Aventis [P/S]
       (S4) XL TABS, 41/5.2/0740     skin rash, prurit., urticar., allerg.reacts., angioed., back pain, myalg.,   Alfuzosin
       716113-001: 10 mg, 30, R396,06  arthralg., musc.cramps/weakn., UTI, dysur., haematur., painf.urinat.,   Indications: Funct.sympts.of benign prostat. hyperplas., adjunct.ther.
       Dosage: Admin.aft.meals.swallow.whole. Do not crush/crunch/  cystit., urin.freq.changes, noctur., urin.incontin., priap., impot., erect.   with urethral catherisat.for ac.urin.retent.relat.to BPH
       chew/grind tab.               dysfunct., gynaecomast., asthen., alopec., fatig., malaise, redden.  (S4) XL TABS, 35/5.2/0074
       Adults: BPH: 1 tab.dly.       sclera, lichen planus, tinnit.  701590-001: 10 mg, 30, R531,13
                       st
       Adjunct.urin.retent: 1 tab.dly. from 1  day of catheterisat.  Special precautions: Coron.insuffic., discont.if sympt.of ang.  Dosage: Admin.aft.meals.swallow.whole.
       Contraindications: Orthostat.hypotens., other concom.alpha 1-  pect.develop./worsen, mild to mod. imp. hepat./ren.funct., poss.  Benign prostat. hyperplas: 1 tab.dly.
                                                                                  st
       adrenocept.block., hepat.insuffic., sev.ren.insuffic., childr.,   syncope aft.init.dos./ incr. dos.in symptomat.hypotens., excl.pros-  Ac.urin.retent: 1 tab.dly.taken.from 1  day of catherisat.
                                     tate Ca bef.init.ther.
       Side effects: Postur.hypotens., faintn., GI disturbs., dry mouth, dizzin.,   Contraindications: Orthostat.hypotens., other concom.alpha 1-
       headache, vertigo., drowsin., malaise, tachycard., syncope, palpitat.,   Drug interactions: Hypotens.eff.potent.by diuret. /other antihy-  adrenocept.block., hepat.insuffic., sev.ren.insuffic., childr.
                                     pertens./alcoh.or other meds.caus. hypotens., sympathomimet.&
       rash, prurit., asthen., flushes, oed., chest pain.  NSAID’s reduc. hypotens.eff.  Side effects: GI disturbs., faintn., headache, vertigo., drowsin., ma-
       Special precautions: Warn pts.of poss. orthostat. hypotens., cont.  laise, tachycard., postur. hypotens., palpitat., ang.pect.with pre-exist.
       coron.artery dis. treatm., discont.if ang.pect.reappears/worsens,   FLOMAX, Astellas Pharma (Pty) Ltd  cornon. artery dis., intraop.floppy iris syndr., rhinit., hepatocellul.in-
       where prev. pronounc.hypotens.respons.to other alpha 1-block.exper.  See Section 16.5  jury, cholestat.liv.dis., rash, prurit., urticar., angioed., asthen., flushes,
       Drug interactions: Poss postur.hypotens.with antihypertens.  oed., chest pain, priapism.
       meds.& alpha 1-adrenocept.block., concom.nitrates, decr.BP.with   OMSAL, Litha Pharma (Pty) Ltd  Special precautions: Symptomat.orthostat. hypotens., do not pre-
       gen.anaesth.                  See Section 16.5             scrib.alone to coron.pts., cont. coron.insuffic.treatm., discont.ther.if
                                                                  ang. pect.reappears/worsens., prev.pronounc. hypotens. respons.
       BENIPROSIN, Unicorn Pharmaceuticals (Pty) Ltd  PRATSIOL, (Aspen Pharmacare: Pharma) Pharmacare [P/S]  to other alpha 1-block., advis. ophthalm.surg.of curr./past alpha1-
       See Section 16.5              Prazosin HCl                 block.ther.to prev.poss.incr.procedur.complicat.risk, take into acc.
                                     Indications: Mild to mod.hypertens.
       CARDUGEN, Mylan [P/S]         (S3) TABS. S/7.1/321, 2.     combin.with nitrates.
                                                                  Drug interactions: Poss postur.hypotens.with antihypertens.meds.,
       Doxazosin.                    782122-019: 1 mg, 100, R156,88  decr.BP.with gen.anaesth., bld.lev.incr.with potent. CYP3A4 inhibit.
       Indications: Mild to mod.hypertens., urin.outflow obstruct.&   782130-003: 2 mg, 100, R266,48
       sympts.assoc.with BPH.        Dosage: First dose at bedt. Init. 0,5 mg 2-3xdly. Maint: Slow incr.
       (S3) TABS, 34/7.1/0271, 0273  as reqd.up to 20 mg/day.
                                     Contraindications: Pregn., childr.und.12 yrs.
       701425-001: 1 mg, 30, R54,34  Side effects: Nasal congest., depress., GI disturbs., drowsin., head- 7.3.3   Beta-receptor blockers
       701426-001: 4 mg, 30, R68,10
       Dosage: Hypertens: Init: 1 mg once dly. Depend. on respons.incr.aft.   ache, post.hypotens., palpit., dyspn., urin.freq., blurr.vis., tinnit., dry   ADCO-BISOCOR (MDR Listing)
       1-2 wks to 2 mg and then at similar interv.to 4 mg, 8 mg and 16 mg   mouth, lethargy, nervousn., oed., chest pain, paraesth., redden.scle-  CARDICOR (MDR Listing)
       to achieve desir.respons. If adeq.control.not achiev.with sngl.agent   ra, diaphores., syncope, skin rash., impot., tachycard., vivid dreams.  ADCO-ATENOLOL, Adcock-Ingram Healthcare (Pty) Ltd
                                     Special precautions: CCF, adren.not to be giv.to antagon. hypotens.
       may be combin.with thiazide diuret./ß-block.               See Section 7.4.2
       BPH: Init: 1 mg once dly. Depend.on urodynam.& BPH symptoma-  eff., poss.enhanc.card. accelerat. eff., lact.intol.
                                     Warnings: Sudd.collapse foll.init.dos.or at any stage of treatm.
       tology dos may be.incr.at interv.of 1-2 wks to 2 mg and then to 4 mg,   ADCO-BISOCOR, AI Pharm Ltd [PWR] &
       with max.of 8 mg. Usual recomm.dos is 2-4 mg dly.  usually aft.dos.increm.  Bisoprolol hemifumarate
       Contra-indications: Safety in pregn.& lactat.not est., no exper.in childr.  RANTRAL MR 10, Ranbaxy [P/S]  Indications: Mild to mod.hypertens., ang.pect.
       Side-effects: CNS effs., hypotens., oed., asthen., abnorm.vis., chest   Alfuzosin HCl  (S3) TABS. 37/5.2/0010, 0011
       pain, GI disturbs., dry mouth, dyspn., palpit., rash, rhinit., sex.dysfunct.,   Indications: Funct.sympts.of benign prostat. hyperplas.  703913-001: 5 mg, 30, R54,30
       tachycard., malaise, urin.incontin., priap., impot., ang. pect., MI,   (S4) MOD.REL.TABS, A40/5.2/0392  703914-001: 10 mg, 30, R93,60
       CVA, card.arrythm., blurr.vis., allerg. reacts., hepatit., jaund., epistax.  715829-001: 10 mg, 30, R265,18  Dosage: Adults: Indiv. 5 -10 mg once dly.in the morn. Max.recomm.
       Special precautions: Monit.BP of BPH pts., imp. liv.funct.  Dosage: Admin.aft.meals.swallow.whole.  dly.dos.20 mg. Sev.ren./hepat. impairm: max.10 mg.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page125.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page121.html">121</a>&nbsp;&nbsp;&nbsp;<a href="page122.html">122</a>&nbsp;&nbsp;&nbsp;<a href="page123.html">123</a>&nbsp;&nbsp;&nbsp;<a href="page124.html">124</a>&nbsp;&nbsp;&nbsp;<a href="page125.html">125</a>&nbsp;&nbsp;&nbsp;<a href="page126.html">126</a>&nbsp;&nbsp;&nbsp;<a href="page127.html">127</a>&nbsp;&nbsp;&nbsp;<a href="page128.html">128</a>&nbsp;&nbsp;&nbsp;<a href="page129.html">129</a>&nbsp;&nbsp;&nbsp;<a href="page130.html">130</a>&nbsp;&nbsp;&nbsp;<a href="page131.html">131</a>
             </td>
             <td width="35%"><a href="page127.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page127.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
